Actively Recruiting

Phase 1
Phase 2
Age: 4Years - 17Years
All Genders
ID07419243

Identification of Mechanisms and Biomarkers Predictive of Tolerance in Children With Food Allergies Comparing Oral Immunotherapy and Natural Evolution

Led by Fundación de Investigación Biomédica - Hospital Universitario de La Princesa · Updated on 2026-02-27

68

Participants Needed

1

Research Sites

30 weeks

Total Duration

On this page

Sponsors

F

Fundación de Investigación Biomédica - Hospital Universitario de La Princesa

Lead Sponsor

F

Fundación para la investigación biomética Hospital Infantil Universitario Niño Jesús

Collaborating Sponsor

AI-Summary

What this Trial Is About

Researchers are investigating food allergies to cow's milk and hen's egg proteins, which are common causes of food allergies in early childhood and can lead to serious reactions, reduced quality of life, and health costs. While many children outgrow these allergies naturally by age 5, some continue to have allergies into adolescence. This study aims to compare natural allergy resolution with oral immunotherapy (OIT), a treatment that gradually introduces small amounts of the allergenic food to increase tolerance, to better understand which approach is more effective for children with mild to moderate allergies who are older than 6 years. The study includes two groups of children aged 4 to 17 years with cow's milk or hen's egg allergies. One group follows the standard care of avoiding the allergenic food, while the other undergoes OIT to build tolerance by taking increasing doses of milk or egg protein. The OIT group consists of children who have achieved full or partial desensitization after about 7 months of treatment. Both groups will be followed for up to 29 months to track their allergy status and immune responses. Participants will have regular assessments including food challenges to test tolerance, questionnaires about quality of life, and monitoring of allergic reactions. Researchers will compare how many children in each group achieve sustained unresponsiveness, meaning they can tolerate the food even after a period of avoidance. They will also evaluate quality of life changes and the safety of the treatments. The study will last about two years for the OIT group and slightly longer for the avoidance group, with ongoing follow-up to understand long-term outcomes.

CONDITIONS

Brief Title

Tolerance Results and Immune Mechanisms in Cow´s Milk and/or Hen´s Egg Allergic Children Following Natural Evolution or Oral Immunotherapy

Who Can Participate

Age: 4Years - 17Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Cow's milk and/or hen's egg allergic patients aged 4 to 10 years for the natural evolution cohort
  • Specific IgE levels to milk or egg extracts between 0.35 to 35 kUA/L
  • Positive open food challenge with milk or egg showing moderate or higher allergic reaction
  • Mild to moderate food allergy severity per DEFASE score (<13 points)
  • Signed informed consent
  • Patients undergoing oral immunotherapy who have achieved full or partial desensitization by month 7 in the compITO study
  • Signed informed consent for oral immunotherapy cohort
Not Eligible

You will not qualify if you...

  • Positive reaction with eliciting dose below target thresholds on entry food challenge
  • Desire or medical need to start oral immunotherapy within 29 months of study entry
  • No allergic reaction greater than mild on baseline challenge for maximum cumulative doses
  • Immunological diseases or immunomodulatory therapies
  • Severe atopic dermatitis per SCORAD
  • Severe allergy per DEFASE score (≥13)
  • Moderate-to-severe airway obstruction or poorly controlled asthma
  • Previous oral immunotherapy for another food
  • Recent treatment with subcutaneous or sublingual aeroallergen immunotherapy
  • Presence or suspicion of eosinophilic esophagitis
  • Non-IgE-mediated milk or egg allergy
  • Pregnancy
  • Significant medical comorbidities (renal, hepatic, cardiac insufficiency, active infections, cancers)
  • Inability to provide informed consent or communication barriers
  • Failure or withdrawal from compITO study for oral immunotherapy cohort
  • Uncontrolled atopic dermatitis or asthma, eosinophilic esophagitis, pregnancy, or significant comorbidities at enrollment for oral immunotherapy cohort

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Treatment

Duration - Up to 24 months

Participants undergo either oral immunotherapy with incremental doses of the allergenic food or follow allergenic food avoidance as standard care.

Regular visits throughout treatment duration

Follow-up

Duration - Up to 5 months post-treatment for natural evolution cohort

Participants are monitored to assess tolerance development and immune mechanisms after treatment or natural evolution.

Periodic visits until month 29 for natural evolution cohort; until month 24 for oral immunotherapy cohort

Trial Site Locations

Total: 1 location

1

Hospital Infantil Universitario Niño Jesús. Avenida de Menéndez Pelayo, número 65

Madrid, Madrid, Spain, 28009

Actively Recruiting

Loading map...

Research Team

P

Pablo Rodríguez del Río, MD PhD

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NON_RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Similar Trials

A Randomised, Controlled Trial Evaluating the Effectiveness ...

Food Allergy in Children

Actively Recruiting

1 location

Comparative Analysis Between Two Oral Immunotherapy Schemes ...

Food Allergy in Children

Actively Recruiting

1 location

Effect of Omalizumab in the Skin of Food Allergy Patients

Food Allergy

Actively Recruiting

1 location

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here